期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Current developments in pharmacological therapeutics for chronic constipation 被引量:24
1
作者 Chunhuan Jiang Qinglong Xu +1 位作者 Xiaoan Wen Hongbin Sun 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2015年第4期300-309,共10页
Chronic constipation is a common gastrointestinal disease severely affecting the patient's quality of life. The traditional treatment of constipation is the use of laxatives. Recently, several new drugs including ... Chronic constipation is a common gastrointestinal disease severely affecting the patient's quality of life. The traditional treatment of constipation is the use of laxatives. Recently, several new drugs including lubiprostone, linaclotide and prucalopride have been approved for treatment of chronic constipation. However, a significant unmet medical need still remains, particularly among those patients achieving poor results by current therapies. The 5-HT4 receptor modulators velusetrag and naronapride,the guanylate cyclase C agonist plecanatide and the ileal bile acid transporter inhibitor elobixibat are recognized as the most promising drugs under investigation. Herein, we give a comprehensive review on the pharmacological therapeutics for the treatment of chronic constipation, with the purpose of reflecting the drug development trends in this field. 展开更多
关键词 Chronic constipation prokinetic agent 5-HT4 receptor Prosecretory agent
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部